Pacific Biosciences of California Inc (PACB)
Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell
$2.12
Buy
$2.14
$-0.05 (-2.30%)
Prices updated at 13 Dec 2025, 00:50 EST
| Prices minimum 15 mins delay
Prices in USD
Pacific Biosciences of California Inc is a biotechnology company. It is engaged in design, development, and manufacture of sequencing system to help scientists resolve genetically complex problems.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2024 | 24.21 |
| 2023 | 26.32 |
| 2022 | 38.22 |
| 2021 | 45.10 |
| 2020 | 41.28 |
| 2019 | 38.04 |
| 2018 | 31.92 |
| 2017 | 37.08 |
| 2016 | 48.68 |
| 2015 | 57.61 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | 4.24 |
| 2024 | 2.86 |
| 2023 | 14.08 |
| 2022 | 13.33 |
| 2021 | 34.52 |
| 2020 | 51.08 |
| 2019 | 9.45 |
| 2018 | 11.17 |
| 2017 | 2.79 |
| 2016 | 3.21 |
| 2015 | 13.27 |
Price/Forward earnings (YTD)
-4.21
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2024 | -20.61 |
| 2023 | -17.46 |
| 2022 | -16.65 |
| 2021 | -14.97 |
| 2020 | 10.46 |
| 2019 | -52.87 |
| 2018 | -65.25 |
| 2017 | -65.39 |
| 2016 | -55.30 |
| 2015 | -24.81 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | 2.49 |
| 2023 | 2.49 |
| 2022 | 3.14 |
| 2021 | 2.54 |
| 2020 | 1.23 |
| 2019 | 2.69 |
| 2018 | 1.49 |
| 2017 | 1.67 |
| 2016 | 1.63 |
| 2015 | 1.78 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
